PT - JOURNAL ARTICLE AU - Pino-González, Manuel AU - Lázaro-Quintela, Martín AU - Alonso-Álvarez, Irene AU - Gallardo-Gómez, María AU - Juaneda-Magdalena, Laura AU - Francisco-Fernández, Alejandro AU - Calabuig-Fariñas, Silvia AU - Jantus-Lewintre, Eloisa AU - Martínez-Fernández, Mónica TI - Tissue and Peripheral T-cell Repertoire Predicts Immunotherapy Response and Progression-Free Survival in NSCLC Patients AID - 10.1101/2024.08.01.24311282 DP - 2024 Jan 01 TA - medRxiv PG - 2024.08.01.24311282 4099 - http://medrxiv.org/content/early/2024/08/02/2024.08.01.24311282.short 4100 - http://medrxiv.org/content/early/2024/08/02/2024.08.01.24311282.full AB - Immunotherapy has opened new avenues of treatment for patients with advanced non-small cell lung cancer (NSCLC) without previous hope of survival. Unfortunately, only a small percentage of patients benefit from it, and it is still not well understood which tumor characteristics can be used to predict immunotherapy response. As the key cellular effectors of antitumor immunity, T cells are endowed with specialized T cell receptors (TCRs) to recognize and eliminate cancer cells. Here, we evaluated the potential of TCR repertoire as a predictive biomarker in patients treated with immunotherapy. With this aim, advanced NSCLC patients treated with immunotherapy at first-line were included. After obtaining peripheral blood and tissue samples at baseline, next-generation sequencing targeting TCRβ/γ was performed. Beyond TCR metrics, clonal space of the most frequent clones was determined. We found a positive association between uneven tumor-infiltrating TCRβ repertoire and the immunotherapy response. Moreover, the use of various tumor-infiltrating and circulating TRBV/J genes predicted the immunotherapy response. Our results indicate the importance of evaluating tissue and circulating TCRβ repertoire prior immunotherapy, showing it as a promising immunotherapy response biomarker in NSCLC patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Instituto de Salud Carlos III (ISCIII) and the European Social Fund ("Investing in your future") (PI21/00348, CP20/00188). MPG is currently supported by a grant for the predoctoral stage (IN606A-2024/017) from the Axencia Galega de Innovacion-GAIN, Xunta de Galicia. MGG is currently supported by a grant for the postdoctoral stage (IN606B-2024/014) from the Axencia Galega de Innovacion-GAIN, Xunta de Galicia. MMF is currently supported by the Miguel Servet program (CP20/00188) from the Instituto de Salud Carlos III (ISCIII).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Galician Regional Research Ethics Committee gave ethical approval for this work (2019/046).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets supporting the findings of this study are available from the corresponding authors upon reasonable request.